Weigao Group’s Controlling Shareholder Lifts Stake to 46.27% After HK$50.90 Million H-Share Buying Spree

Bulletin Express06-05

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that controlling shareholder Weigao Holding has expanded its position in the company’s H-shares through open-market purchases.

Between 13 May 2026 and 5 June 2026, Weigao Holding acquired a cumulative 14.95 million H-shares for approximately HK$50.90 million. The latest tranche—11.40 million shares bought from 15 May 2026 to 5 June 2026—represents 0.25% of both Weigao Group’s issued H-shares and total share capital.

Following the transactions, Weigao Holding’s ownership stands at 2.11 billion H-shares, equal to 46.76% of the company’s H-share float and 46.27% of total issued shares. The board highlighted that the purchases signal the shareholder’s confidence in Weigao Group’s long-term prospects.

The company reminded shareholders and potential investors to exercise caution when trading its securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment